Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
ASG, Inc.
CRO Acquisition Seen Boosting Activity, Positioning ASG, Inc., for New Growth in Q2
May 20th, 2009
ASG, Inc., saw continued growth in the first quarter following its acquisition of neighboring Ockham Development Group. The February merger with the full-service contract research organization sought to expand the breadth and value of services that Cary, North Carolina-based ASG provides clients requiring functional outsourcing and staffing services or the opportunity to outsource an entire clinical trial. ASG's CEO Jim Baker said, "I am pleased to announce that we continue to make progress in merging the two companies into one." Through Ockham, ASG has secured new work in the therapeutic areas of oncology, anti-infectives, and...
Source: Vaccine Weekly (2009-05-20)
|
